UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Correction to: Dental caries and dental developmental defects as adverse effects of antineoplastic treatment in childhood cancer survivors

European archives of paediatric dentistry, 2023-06, Vol.24 (3), p.367-367

2023

Volltextzugriff (PDF)

Dental caries and dental developmental defects as adverse effects of antineoplastic treatment in childhood cancer survivors

European archives of paediatric dentistry, 2023-06, Vol.24 (3), p.357-365

2023

Volltextzugriff (PDF)

Insights from the Greek experience of the use of Blinatumomab in pediatric relapsed and refractory acute lymphoblastic leukemia patients

Neoplasma, 2020-11, Vol.67 (6), p.1424-1430

2020

Volltextzugriff (PDF)

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW

HemaSphere, 2022-06, Vol.6 (Suppl), p.2101-2102

2022

Volltextzugriff (PDF)

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION THERAPY WITH DEFERIPRONE AND DEFERASIROX IN PATIENTS WITH Β‐THALASSEMIA MAJOR: A SYSTEMATIC LITERATURE REVIEW

HemaSphere, 2022-06, Vol.6 (Suppl), p.1392-1393

2022

Volltextzugriff (PDF)

Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion

Nephrology, dialysis, transplantation, 2008-12, Vol.23 (12), p.3874-3879

2008

Volltextzugriff (PDF)

Stability of amorphous-silicon TFTs deposited on clear plastic substrates at 250 °C to 280 ° C

IEEE electron device letters, 2006-02, Vol.27 (2), p.111-113

2006

Volltextzugriff (PDF)

S124: ADVERSE EVENTS FOLLOWING COVID‐19 VACCINATION IN TRANSFUSION‐DEPENDENT ‐THALASSEMIA PATIENTS

HemaSphere, 2022-01, Vol.6 (Suppl), p.13-13

2022

Volltextzugriff (PDF)

P1521: A SEVERE MOUSE MODEL OF ALPHA‐THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH

HemaSphere, 2022-06, Vol.6 (Suppl), p.1402-1403

2022

Volltextzugriff (PDF)

P1506: REAL‐WORLD DATA ON THE USE OF LUSPATERCEPT IN GREEK PATIENTS WITH TRANSFUSION DEPENDENT THALASSEMIA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1387-1388

2022

Volltextzugriff (PDF)

P1517: REAL‐WORLD COMPLICATION BURDEN AND DISEASE MANAGEMENT IN TRANSFUSION‐DEPENDENT ADULTS WITH ΒETA‐THALASSEMIA (Β‐THAL) IN GREECE: FINAL RESULTS OF THE EPIDEMIOLOGICAL CROSS‐SECTIONAL ULYSSES STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1398-1399

2022

Volltextzugriff (PDF)

5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION‐DEPENDENT‐THALASSEMIA AND SEVERE SICKLE CELL DISEASE

HemaSphere, 2023-04, Vol.7 (S1), p.2-3

2023

Volltextzugriff (PDF)

S104: A SEVERE MOUSE MODEL OF ALPHA‐THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH

HemaSphere, 2022-01, Vol.6 (Suppl), p.2-3

2022

Volltextzugriff (PDF)

P112: ENERGIZE AND ENERGIZE‐T: TWO PHASE 3, RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON‐‐TRANSFUSION‐DEPENDENT OR TRANSFUSION‐DEPENDENT ALPHA‐ OR BETA‐THALASSEMIA

HemaSphere, 2022-01, Vol.6 (Suppl), p.23-24

2022

Volltextzugriff (PDF)

P1507: CLINICAL PROFILE OF COVID‐19 INFECTION AND IMMUNE RESPONSE AFTER 3AND6 MONTH VACCINATION AGAINST SARS‐COV‐2 IN ADULT PATIENTS WITH TRANSFUSION‐DEPENDENT THALASSAEMIA‐THE EXPERIENCE OF A GREEK CENTER

HemaSphere, 2022-06, Vol.6 (Suppl), p.1388-1389

2022

Volltextzugriff (PDF)

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

The New England journal of medicine, 2021-01, Vol.384 (3), p.252-260

2021

Volltextzugriff (PDF)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

Drug design, development and therapy, 2016-01, Vol.10, p.4073-4078

2016

Volltextzugriff (PDF)

Uptake of Non-Transferrin Iron by Erythroid Cells

Anemia, 2011-01, Vol.2011, p.945289-8

2011

Volltextzugriff (PDF)

PB1914: CYTOGENETIC FINDINGS IN 18 CHILDREN WITH MYELODYSPLASTIC SYNDROMES BY KARYOTYPIC AND FISH ANALYSIS

HemaSphere, 2022-06, Vol.6 (Suppl), p.1793-1794

2022

Volltextzugriff (PDF)

P1518: LONG‐TERM SAFETY RESULTS OF THE BELIEVE STUDY OF LUSPATERCEPT IN ADULTS WITH ΒETA‐THALASSEMIA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1399-1400

2022

Volltextzugriff (PDF)

S270: LONGER‐TERM ANALYSIS OF EFFICACY OF LUSPATERCEPT VERSUS PLACEBO IN PATIENTS WITH TRANSFUSION‐DEPENDENT BETA‐THALASSEMIA ENROLLED IN THE BELIEVE STUDY

HemaSphere, 2022-06, Vol.6, p.171-172

2022

Volltextzugriff (PDF)

ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA

Hematology, Transfusion and Cell Therapy, 2021-10, Vol.43, p.S20-S20

2021

Volltextzugriff (PDF)

The Economic Burden of Treating Thalassemia In Greece

Value in health, 2014-11, Vol.17 (7), p.A526-A526

2014

Volltextzugriff (PDF)

Athens University thalassemia expertise unit: evolution, structure, perspectives and patients' expectations

Georgian medical news, 2013-09 (222), p.94-98

2013

Volltextzugriff (PDF)

Heart failure in beta thalassemia: a 5-year follow-up study

The American journal of medicine, 2001-10, Vol.111 (5), p.349-354

2001

Volltextzugriff (PDF)

1 – 25 von 902

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(773)
Mit Volltextzugriff
(714)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(395)
Humans
(333)
Life Sciences & Biomedicine
(315)
Male
(184)
Hematology
(180)
Female
(176)
Child
(161)
Adolescent
(136)
Adult
(130)
Child, Preschool
(90)
Biological And Medical Sciences
(85)
Medical Sciences
(84)
Pediatrics
(77)
Thalassemia
(75)
Technology
(71)
Greece
(65)
Infant
(63)
Hematologic And Hematopoietic Diseases
(59)
Materials Science
(58)
Oncology
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(116)
British Journal Of Haematology
(50)
The Lancet
(32)
Acta Bio-Medica De L'ateneo Parmense
(31)
Acta Bio-Medica : Atenei Parmensis
(30)
Hemasphere
(29)
Mediterranean Journal Of Hematology And Infectious Diseases
(26)
Hemoglobin
(17)
Journal Of Materials Science
(17)
Haematologica
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Correction to: Dental caries and dental developmental defects as adverse effects of antineoplastic treatment in childhood cancer survivors

Dental caries and dental developmental defects as adverse effects of antineoplastic treatment in childhood cancer survivors

Insights from the Greek experience of the use of Blinatumomab in pediatric relapsed and refractory acute lymphoblastic leukemia patients

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION THERAPY WITH DEFERIPRONE AND DEFERASIROX IN PATIENTS WITH Β‐THALASSEMIA MAJOR: A SYSTEMATIC LITERATURE REVIEW

Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion

Stability of amorphous-silicon TFTs deposited on clear plastic substrates at 250 °C to 280 ° C

S124: ADVERSE EVENTS FOLLOWING COVID‐19 VACCINATION IN TRANSFUSION‐DEPENDENT ‐THALASSEMIA PATIENTS

P1521: A SEVERE MOUSE MODEL OF ALPHA‐THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH

P1506: REAL‐WORLD DATA ON THE USE OF LUSPATERCEPT IN GREEK PATIENTS WITH TRANSFUSION DEPENDENT THALASSEMIA

P1517: REAL‐WORLD COMPLICATION BURDEN AND DISEASE MANAGEMENT IN TRANSFUSION‐DEPENDENT ADULTS WITH ΒETA‐THALASSEMIA (Β‐THAL) IN GREECE: FINAL RESULTS OF THE EPIDEMIOLOGICAL CROSS‐SECTIONAL ULYSSES STUDY

5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION‐DEPENDENT‐THALASSEMIA AND SEVERE SICKLE CELL DISEASE

S104: A SEVERE MOUSE MODEL OF ALPHA‐THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH

P112: ENERGIZE AND ENERGIZE‐T: TWO PHASE 3, RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON‐‐TRANSFUSION‐DEPENDENT OR TRANSFUSION‐DEPENDENT ALPHA‐ OR BETA‐THALASSEMIA

P1507: CLINICAL PROFILE OF COVID‐19 INFECTION AND IMMUNE RESPONSE AFTER 3AND6 MONTH VACCINATION AGAINST SARS‐COV‐2 IN ADULT PATIENTS WITH TRANSFUSION‐DEPENDENT THALASSAEMIA‐THE EXPERIENCE OF A GREEK CENTER

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

Uptake of Non-Transferrin Iron by Erythroid Cells

PB1914: CYTOGENETIC FINDINGS IN 18 CHILDREN WITH MYELODYSPLASTIC SYNDROMES BY KARYOTYPIC AND FISH ANALYSIS

P1518: LONG‐TERM SAFETY RESULTS OF THE BELIEVE STUDY OF LUSPATERCEPT IN ADULTS WITH ΒETA‐THALASSEMIA

S270: LONGER‐TERM ANALYSIS OF EFFICACY OF LUSPATERCEPT VERSUS PLACEBO IN PATIENTS WITH TRANSFUSION‐DEPENDENT BETA‐THALASSEMIA ENROLLED IN THE BELIEVE STUDY

ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA

The Economic Burden of Treating Thalassemia In Greece

Athens University thalassemia expertise unit: evolution, structure, perspectives and patients' expectations

Heart failure in beta thalassemia: a 5-year follow-up study

Suchergebnisse filtern